INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Mar 11, 2020 |
Director, President and Chief Scientific
Trans History: 572
|
Director, President and Chief Scientific | Other acquisition or disposition | -- | -- |
| Mar 11, 2020 |
Director, President and Chief Scientific
Trans History: 572
|
Director, President and Chief Scientific | Other acquisition or disposition | -- | -- |
| Mar 11, 2020 |
Director, President and Chief Scientific
Trans History: 572
|
Director, President and Chief Scientific | Other acquisition or disposition | -- | -- |
| Feb 28, 2020 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
| Feb 28, 2020 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
| Feb 28, 2020 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
| Feb 27, 2020 |
EVP & General Mgr Industrial O
Trans History: 231
|
EVP & General Mgr Industrial O | Other acquisition or disposition | -- | -- |
| Feb 26, 2020 |
EVP Finance CFO
Trans History: 310
|
EVP Finance CFO | Other acquisition or disposition | -- | -- |
| Feb 25, 2020 |
Director
Trans History: 394
|
Director | Other acquisition or disposition | -- | -- |
| Feb 25, 2020 |
Director
Trans History: 394
|
Director | Other acquisition or disposition | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.